
Deferasirox Tablets
| Product/Composition | Deferasirox Tablets |
|---|---|
| Strength | 500mg |
| Form | Tablets |
| Production Capacity | 10 Million Tablets/Month |
| Packaging | 1 X 10 Tablets / Box |
| Therapeutic use | Anti Cancer |
| Package Insert/Leaflet | Available upon request |
Deferasirox Tablets are a medicine used as an iron chelator, which means they help remove excess iron from the body.
Here are the key details:
-
Composition: Each tablet contains Deferasirox as the active ingredient, available in different strengths such as 90 mg, 180 mg, and 360 mg.
-
Dosage Form: Oral tablets, often available as film-coated tablets or dispersible tablets.
-
Mode of Action: Deferasirox binds to excess iron in the blood (especially iron that accumulates after frequent blood transfusions) and forms a complex that is excreted mainly through the stool. This reduces harmful iron overload in vital organs.
-
Uses:
-
Treatment of chronic iron overload in patients receiving regular blood transfusions (such as those with thalassemia major, sickle cell anemia, or other chronic anemias).
-
Sometimes used in patients with non-transfusion-dependent thalassemia who develop iron overload.
-
-
Treatment Goal: To prevent long-term organ damage (like to the liver, heart, and endocrine system) caused by excess iron accumulation.
-
Side Effects:
-
Common: nausea, vomiting, abdominal pain, constipation, diarrhea, rash.
-
Serious: kidney problems, liver problems, hearing or vision disturbances, gastrointestinal bleeding.
-
-
Precautions:
-
Requires regular monitoring of kidney and liver function.
-
Blood iron levels (serum ferritin) should be checked regularly to adjust dosage.
-
Not recommended in patients with severe kidney or liver impairment.
-
Caution with other medicines that affect kidney or liver.
-
Not generally advised during pregnancy unless clearly needed.
-